Clinical Research & Trials

VibraCool® Reduces Pain 340% More Than TENS

“The authors found the VibraCool® device to be a valuable adjunct to our clinical treatments, especially for very difficult to-treat [tendinopathies]…

  • VibraCool® reduces physical therapy pain 240-340% better than TENS.
  • VibraCool recommended best value for Home Physical Therapy.
  • VibraCool® treats pain from muscle tension and restriction in tendinopathies.
 

“The authors found the VibraCool® device to be a valuable adjunct to our clinical treatments, especially for very difficult-to-treat [tendinopathies]…Patients showed both high compliance and tolerance; chronic pain patients who had some hypersensitivity to general tactile stimulation did fine with the unit.”

Practical Pain Management again recommended VibraCool for home physical therapy and telePT during COVID-19.

 

REFERENCE:

 

Tiziano M, Majewski M., Pain Therapy Options for Home: a patient-based outcome review of at-home pain management devices, including Willow Curve, Quell, and

 

VibraCool. Practical Pain Management 19(1):56-59.

 

Tiziano M, Baxter AL. ,Crossover trial of novel mechanical oscillatory strain therapy device versus TENS for musculoskeletal pain. AAPM&R 11 2019 San Antonio, TX

Patients Using VibraCool® After ACL Surgery Used 35% Fewer Opioids

Effects of Focal Vibration on Pain and Opioid Usage following ACL Reconstruction: A Pilot Study. AAPM&R 11 2019 San
  • [VibraCool] Patients reported using an average of 10.1±3 opioid tablets in the first week following surgery….and only 4 patients continued to use opioids by their first post-operative visit (4.3±2.3 days post-surgery).
  • In a coached group attempting to reduce opioids at the same institution, the average was 35% higher (15.6±8.5).

 

REFERENCE:

 

Effects of Focal Vibration on Pain and Opioid Usage following ACL Reconstruction: A Pilot Study. AAPM&R 11 2019 San

Buzzy® Improved Adherence to Monthly Intramuscular Injections

Penicillin injection adherence for rheumatic heart disease had been a problem. After 3 uses in a special clinic for non-adherent patients, pain and fear dropped by half.
  • Penicillin injection adherence for rheumatic heart disease had been a problem. After 3 uses in a special clinic for non-adherent patients, pain and fear dropped by half. Since adherence was much improved, the special clinic was disbanded.
  • Buzzy was added to the National Guidelines for needle pain in New Zealand.

 

REFERENCE:

 

Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health. 2014;50(2):112-117. doi:10.1111/jpc.12400

KidShot_rgb_hd

Meta-Analyses: Pain Care Labs Technology the most effective IV and injection pain intervention, 50+ Independent Clinical Trials.

“The Buzzy intervention should be used when children are undergoing IM injections to reduce their levels of pain and fear.” – Yilmaz et al.
  • “The Buzzy intervention should be used when children are undergoing IM injections to reduce their levels of pain and fear.” – Yilmaz et al.
  • For adults receiving IM Diclofenac, Buzzy reduced pain 74% and satisfaction with the injection was 95 v. 84. P<.001 – Sahin et al

 

REFERENCE:

 

Ballard A Khadra C, Adler S, Doyon-Trottier E, Le May S. Efficacy of the Buzzy Device for Pain Management during Needle-Related Procedures: A Systematic Review and Meta-analysis. Clin J Pain. 2019 Feb 28 (N= 1138, pain reduction -1.11; 95% confidence interval [CI]: -1.52 to -0.70; P<0.0001) , anxiety reduction (SMD -1.37; 95% CI: -1.77 to 0.96; P<0.00001)